Preface to the dosimetric characteristic of proton radiotherapy for tumors

doi:10.3760/cma.j.cn371439-20250217-00075

Journal of International Oncology ›› 2025, Vol. 52 ›› Issue (7): 432-433.doi: 10.3760/cma.j.cn371439-20250217-00075

• Dosimetric characteristics of proton radiotherapy • Previous Articles Next Articles

Preface to the dosimetric characteristic of proton radiotherapy for tumors

Zhu Jian¹^,²()

¹Department of Radiation Oncology Physics，Shandong Cancer Hospital and Institute，Shandong First Medical University and Shandong Academy of Medical Sciences，Jinan 250117，China
²Shandong Provincial Key Medical and Health Laboratory of Pediatric Cancer Precision Radiotherapy （Shandong Cancer Hospital），Jinan 250117，China

Received:2025-02-17 Revised:2025-04-07 Online:2025-07-08 Published:2025-07-23
Contact: Zhu Jian E-mail:zhujian@sdfmu.edu.cn
Supported by:
National Science and Technology Major Project of China(2024ZD0519901);National Natural Science Foundation of China(82172072);Key R&D Program of Shandong Province，China(2024CXPT084)

Abstract

Abstract:

Proton beam have been widely used in the field of tumor radiotherapy due to the significant physical dosimetric advantages. This series of studies enrolled typical tumor target areas，including the head and neck，whole central nervous system，lungs，esophagus，breast，abdominal and pelvic cavities，and developed both proton and photon radiotherapy plans to compare and evaluate the dosimetric characteristics provided by the two techniques. These studies aim to reflect the dosimetric differences between proton and photon radiotherapy，thus providing references for doctors' clinical decision-making and patients' medical choices.

Key words: Neoplasms, Radiotherapy, Proton therapy, Radiotherapy dosage

Zhu Jian. Preface to the dosimetric characteristic of proton radiotherapy for tumors[J]. Journal of International Oncology, 2025, 52(7): 432-433.

[1]	国家卫生健康委. 关于2019年甲类大型医用设备配置许可的通告(国卫通﹝2019﹞12号)[EB/OL]. (2019-10-09)[2025-02-03]. https://zwfw.nhc.gov.cn/kzx/tzgg/jldxyysbpzxksp_229/201910/t20191009_1300.html.
[2]	国家卫生健康委. 国家卫生健康委关于发布“十四五”大型医用设备配置规划的通知(国卫财务发〔2023〕18号)[EB/OL].(2023-06-29)[2025-02-03]. https://zwfw.nhc.gov.cn/kzx/tzgg/jldxyysbpzxksp_229/202306/t20230630_2544.html.
[3]	中国医师协会放射肿瘤治疗医师分会. 早期非小细胞肺癌立体定向放射治疗指南[J]. 国际肿瘤学杂志, 2022, 49(1): 1-11. DOI: 10.3760/cma.j.cn371439-20210621-00001.
[4]	Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy[J]. Int J Radiat Oncol Biol Phys, 2002, 53(2): 407-421. DOI: 10.1016/s0360-3016(02)02754-2.
[5]	Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic[J]. Int J Radiat Oncol Biol Phys, 2010, 76(3 Suppl): S10-9. DOI: 10.1016/j.ijrobp.2009.07.1754.

[1]	Radiation Oncology Professional Committee of the Chinese Research Hospital Association, Hebei Society of Mathematical and Physical Medicine, Tianjin Precision Medicine Society. Expert consensus on the clinical diagnosis and treatment of post-obstructive pneumonia in newly diagnosed lung cancer patients [J]. Journal of International Oncology, 2025, 52(8): 484-494.
[2]	Li Guangxin, Quan Huijuan, Gao Zhijuan, Wang Xiaojun, Li Liang, Dong Qian, Miao Yongtao, Liu Dongsheng. Correlation between serum levels of HAMP， SPP1， RGS2 and clinical pathological characteristics of gastric cancer patients and their predictive value for postoperative recurrence or metastasis [J]. Journal of International Oncology, 2025, 52(8): 502-507.
[3]	Chen Jun, Tang Dandan, Zhou Yuxin, Tan Yuting, Li Honglan, Xu Qun, Xiang Yongbing. Time trend analysis of the disease burden of colorectal cancer among young and middle-aged adults in China from 1990 to 2021 [J]. Journal of International Oncology, 2025, 52(8): 508-516.
[4]	Huang Jinfa, Zheng Lianqiu, Wu Jinpiao, Liu Deting, Chen Huiling. Prediction model for post-TACE infection risk in elderly patients with liver cancer [J]. Journal of International Oncology, 2025, 52(8): 517-522.
[5]	Zhang Baihong, Yue Hongyun. Novel therapeutic strategies： targeting cancer metastasis [J]. Journal of International Oncology, 2025, 52(8): 528-531.
[6]	Guo Junlong, Zou Ruiqi, Chen Shaoqiang, Liang Yuxin, Li Jing, Yong Sunan, He Yuting, Xie Xiaobing, Li Ping. Research progress of RNA m⁶A modification in breast cancer [J]. Journal of International Oncology, 2025, 52(8): 532-537.
[7]	Wu Xin, Ren Haipeng. Research progress of KRAS^G12C inhibitors in the treatment of advanced colorectal cancer [J]. Journal of International Oncology, 2025, 52(8): 538-542.
[8]	Liu Qi, Qu Guobin, Zhu Jian, Wu Fan. Feasibility study of using dual-energy CT virtual non-contrast images to replace true non-contrast images in photon and proton radiotherapy dose calculations [J]. Journal of International Oncology, 2025, 52(7): 401-408.
[9]	Li Xiaoxuan, Xia Zhipeng, Luan Rumei, Wan Yunyan, Yao Zhouhong, Lin Xinshan, Lin Dianjie. Clinical value of metabolomics in assessing the malignant risk of pulmonary nodules [J]. Journal of International Oncology, 2025, 52(7): 409-413.
[10]	Wu Shizhang, Hu Man, Dai Tianyuan, Li Chengqiang, Tao Cheng, Duan Jinghao, Chen Jinhu, Bai Tong, Kong Tian, Zhu Jian. Analysis of dosimetric characteristics of proton radiotherapy in 1 case of whole central nervous system tumor [J]. Journal of International Oncology, 2025, 52(7): 434-440.
[11]	Xu Jian, Duan Jinghao, Liu Qingzeng, Zhu Jian. Correlation study of spectral CT parameters and MRI ADC changes in proton radiotherapy for chordoma [J]. Journal of International Oncology, 2025, 52(7): 441-447.
[12]	Li Chengqiang, Wang Yungang, Yu Yishan, Wu Shizhang, Tao Cheng, Ma Xingmin, Dai Tianyuan, Duan Jinghao, Chen Jinhu, Bai Tong, Zhu Jian. Analysis of dosimetric characteristics of proton radiotherapy in 4 cases of breast cancer [J]. Journal of International Oncology, 2025, 52(7): 448-454.
[13]	Duan Jinghao, Yue Jinbo, Tao Cheng, Wu Shizhang, Li Chengqiang, Dai Tianyuan, Chen Jinhu, Bai Tong, Zhu Jian. Analysis of dosimetric characteristics of proton radiotherapy in 3 cases of abdominal and pelvic tumors [J]. Journal of International Oncology, 2025, 52(7): 455-461.
[14]	Zhang Yanping, Xue Jincai, Xin Yuanchun, Liu Qinjiang, Dong Fang. Research progress on nasopharyngeal carcinoma in children and adolescents [J]. Journal of International Oncology, 2025, 52(6): 337-342.
[15]	Hao Chunhai. Efficacy of rapamycin arterial perfusion combined with ¹³¹I-FAP loaded dextran microspheres for interventional embolization in the treatment of rabbits with liver transplantation tumor [J]. Journal of International Oncology, 2025, 52(6): 353-359.

Preface to the dosimetric characteristic of proton radiotherapy for tumors

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 5

Related Articles 15

Recommended Articles

Metrics

Comments